PTBP1 and colorectal carcinoma: The phenomenon of drug resistance in CRC cells towards vincristine and oxaliplatin can be effectively addressed by the genetic manipulation of polypyrimidine tract binding protein 1 (PTBP1) by means of knockout techniques (Cheng et al., 2018), a key regulator of the glycolytic pathway.